Biperiden

Quick links to important sections

Biperiden

Method of action: Antiparkinsonian

Medically reviewed

Marina Burgos

Last updated on 10/01/2026

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Biperiden

Quick Facts

Property Description
Active Ingredient Biperiden hydrochloride
Form Tablets, Solution for Injection
Pharmacological Class Anticholinergic Agent
General Purpose Management of motor symptoms (e.g., stiffness, tremor)
Origin Synthetic Compound (Piperidine Derivative)

What Type of Medicine is Biperiden?

Biperiden is a prescription-only medicine officially classified as an anticholinergic agent, specifically an antimuscarinic agent. It is a synthetic compound, derived from the piperidine structure, designed to act predominantly within the central nervous system (CNS). The active chemical substance is Biperiden hydrochloride, and it is formulated as a single-ingredient product. Anticholinergic agents like Biperiden are clinically recognized for their central action in neurology.


What is Biperiden’s General Therapeutic Purpose?

The primary therapeutic purpose of Biperiden stems from its ability to reduce the influence of the chemical messenger acetylcholine through a mechanism known as muscarinic receptor antagonism. This action is critical for helping to restore the dopamine/acetylcholine balance within key brain structures. Biperiden is recognized as an essential medicine, a distinction supported by global consensus on efficacy. This confirms its established role in managing and relieving motor symptoms, such as muscular rigidity, stiffness, and tremor, which is a typical use scenario for patients experiencing neurological imbalance.


What Forms of Biperiden are Available?

Biperiden is supplied in two main pharmaceutical forms: as solid oral preparations (tablets) and as a sterile solution for injection. The active ingredient, Biperiden hydrochloride, is prepared either for daily ingestion in tablet form or dissolved into an aqueous solution intended for parenteral administration by a healthcare professional. The availability of the injection form is a key differentiating factor, allowing for use in acute settings where rapid onset of effect is required, distinguishing it from oral-only alternatives.

Regulatory References

  1. WHO Model List of Essential Medicines
  2. WHO Essential Medicines List

What side effects are possible with Biperiden?

Biperiden's safety profile is primarily characterized by anticholinergic effects, which can be peripheral (e.g., affecting glands and smooth muscle) and central (e.g., affecting the central nervous system). Adverse reactions are often dose-dependent and may be more pronounced at the start of treatment or with rapid dose escalation.

Adverse Reactions

The most commonly documented anticholinergic effects affecting various body systems include:

System Organ Class Rare Adverse Reactions Very Rare Adverse Reactions
Psychiatric Excitement, confusion, delirium, hallucinations, sleeplessness (in higher doses) Nervousness, euphoria
Nervous System Fatigue, dizziness, disturbance of memory Headache, dyskinesia, ataxia, convulsions
Eye Disorders Tachycardia Disturbance of accommodation, mydriasis, photosensitivity, closed-angle glaucoma
Gastrointestinal Dryness of mouth, nausea, gastric disorder Constipation
Renal/Urinary Muscle twitching Voiding disorders, urinary retention

Serious adverse reactions reported in regulatory sources include an increased disposition to cerebral seizures and convulsions and the potential to precipitate closed-angle glaucoma, which requires intraocular pressure control. Hypersensitivity reactions are also listed as very rare.

Safety Considerations and Restrictions

Contraindications listed in official documents include known hypersensitivity to the drug, untreated narrow-angle glaucoma, paralytic ileus or other mechanical stenoses of the gastrointestinal tract, and myasthenia gravis.

Cautions are advised for elderly patients, patients with an enlarged prostate (due to the risk of urinary retention), those with a known history of seizures, and those with potentially dangerous tachycardia. Central excitation effects are frequently observed in patients with cerebral deficiencies and may require a dosage reduction. The drug may impair the ability to drive or operate machinery, and abrupt cessation should be avoided due to the danger of excessive counter-regulation.

Overdose and Emergency Response

Overdose and when to seek help

Overdose of Biperiden hydrochloride is officially documented as the Central Anticholinergic Syndrome, which affects the Central Nervous System, Cardiovascular System, and other physiological functions. Documented clinical manifestations of overdose include peripheral signs such as dilated, sluggish pupils, warm, dry skin, facial flushing, and elevated body temperature. Neuropsychiatric signs include delirium, confusion, anxiety, hallucinations, and combativeness.

When to Seek Immediate Medical Help

Regulatory authorities mandate that emergency medical attention must be sought immediately if an overdose is suspected. This is due to the potential for the condition to progress rapidly to severe outcomes, including seizures, stupor, coma, paralysis, cardiac arrest, or respiratory arrest, which can result in death. Patients are instructed to contact a doctor or proceed to the nearest hospital casualty department.

Management and Specific Considerations

Treatment for overdose primarily involves symptomatic and supportive therapy. Procedures such as gastric lavage or measures to limit drug absorption may be instituted. The official labeling notes that specific severe manifestations, such as delirium, hallucinations, and supraventricular tachycardia, seem to respond to physostigmine, an anticholinesterase agent, although this response is constrained to certain symptoms. Elderly patients are cited as a population requiring cautious dosing due to potential increased sensitivity.

Therapeutic Uses of Biperiden

Biperiden is a medication used to help manage symptoms associated with certain neurological conditions. It is indicated as an adjunct in the therapy of all forms of parkinsonism, which includes idiopathic, postencephalitic, and arteriosclerotic types, and for the control of extrapyramidal disorders secondary to neuroleptic drug therapy. These extrapyramidal symptoms are movement difficulties often caused by other medications and may include acute muscle spasms (dystonia) and restlessness (akathisia). The primary patient benefit is the relief of movement symptoms, such as muscle stiffness, poor control, and involuntary tremors. This therapeutic effect helps support the patient’s ability to move more comfortably and maintain daily function.


Quick Fact: Relief for Muscle Stiffness

Eligibility and Restrictions for Use

Biperiden is an anticholinergic medicine for which eligibility is strictly defined by official regulatory documentation, focusing on contraindications and patient vulnerability.

Contraindications and Restrictions

Classification Population or Condition
Absolute Contraindication Known hypersensitivity to Biperiden; untreated narrow-angle glaucoma; and bowel obstruction (e.g., paralytic ileus, megacolon).
Conditional Use Caution Patients with prostatic hypertrophy (risk of urinary retention), cardiac arrhythmias, and epilepsy or a tendency to convulsions.

Age-Related Eligibility

Use in children is generally categorized as safety and efficacy not established by some regulators. Experience is limited, mainly restricted to short-term use in children aged 3–15 for drug-induced movement disorders. Older adults require cautious dosing and careful monitoring due to an increased risk of central nervous system side effects like confusion or delirium.

Reproductive Status Eligibility

For pregnancy, Biperiden is often classified as FDA Category C, meaning the risk cannot be ruled out. It should be used only if the potential benefit justifies the risk. Use during lactation is generally not recommended or requires caution, as the drug is presumed to pass into breast milk and may potentially inhibit lactation.

What should I know about interactions with other medicines?

Biperiden Interactions with other Medicines and Products

Official regulatory information describes Biperiden's interaction profile primarily through additive pharmacodynamic effects, which may result from co-administration with other substances acting on the central or autonomic nervous systems.

Documented Interaction Categories

Product Category Officially Documented Effect Constraint/Note (Regulatory)
Other Anticholinergics Increased central and peripheral anticholinergic effects (e.g., dry mouth, confusion) Use-with-caution is generally advised due to additive risk.
CNS Depressants Additive Central Nervous System (CNS) effects (e.g., increased drowsiness, sedation) Caution for combinations with narcotics, sedatives, and similar agents.
Prokinetic Agents Biperiden reduces the effect of compounds like Metoclopramide Due to Biperiden’s own effect on gastrointestinal motility.
Levodopa/Carbidopa Associated with reports of generalized choreiform movements Cautionary note on potential for movement disturbances.
Alcohol (Ethanol) Additive CNS effects (e.g., increased dizziness and drowsiness) Consumption must be avoided as per prescribing information.

Regulatory Constraints and Cautions

While no medicinal products are listed as formal contraindications for co-administration in standard therapy, Phenothiazines are officially contraindicated for use in treating a Biperiden overdose, as their antimuscarinic action may intensify toxicity.

Regulatory documents specify that elderly patients are particularly sensitive to Biperiden's central anticholinergic effects. This population-specific caution means interactions with other CNS-acting drugs may be more clinically pronounced in older adults. No mandatory dose-timing separation requirements are specified for any drug or product combination.

Mechanism of Action

How Biperiden Works: The Central Mechanism

Biperiden's mechanism of action is defined by its selective influence on central neurotransmitter systems, centered on the modulation of activity within motor control pathways.


Blocking Central Muscarinic Receptors

The foundational mechanism involves Biperiden acting as a competitive antagonist by blocking muscarinic acetylcholine receptors, primarily the M₁ subtype, in the brain's movement control center, the basal ganglia. This targeted blockade reduces the effects of the neurotransmitter acetylcholine within these structures.


Adjusting Dopamine-Acetylcholine Signaling

The reduction in acetylcholine activity achieved by the receptor blockade functionally adjusts the critical dopamine-acetylcholine signaling ratio within the striatum. This mechanism operates in systems where targeted pathway adjustment is required to normalize the functional relationship between these two competing neurotransmitters. This adjustment modifies early molecular steps that shape systemic motor outcomes.


Modulating Extrapyramidal Motor Control

The resulting adjusted balance initiates a mechanistic cascade that contributes to modulating dysregulated signaling patterns within the extrapyramidal motor system. This key pathway effect results in physiological adjustments, promoting a shift in signaling activity within the targeted motor circuits.

Dosage and Administration Information

Biperiden is structured for both long-term and acute use, with administration guided by established clinical protocols.

Administration Scope

The medicine is supplied for oral administration via tablets for maintenance therapy and as a solution for injection for the rapid control of acute extrapyramidal symptoms.

Instruction Category Standard Guidelines
Route of administration Oral (tablets); Intramuscular (IM) or Intravenous (IV) infusion for acute use.
Dosing schedule Initial dose must begin low (e.g., 1 mg to 2 mg) and be gradually increased (titrated). The adult maximum daily dose must not exceed 16 mg.
Timing in relation to meals Tablets should be taken with sufficient liquid and preferably during or immediately after a meal to minimize potential gastric irritation.
Age-group rules Older Adults require cautious, low initial dosing. Pediatric (3 to 15 years) dosage is a divided daily total ranging from 1 mg to 6 mg.
Special procedural conditions IV administration must be performed slowly. Cessation requires a step-wise, gradual dose reduction (tapering).

Resulting Procedural Structure

The protocol establishes a structured course that requires initial dose titration to determine the appropriate individualized dose, followed by a maintenance phase using divided daily oral doses. This course is distinguished by the availability of an acute parenteral route for rapid intervention, and necessitates a slow, step-wise reduction in dosage upon eventual discontinuation, defining the full administrative management of the medicine.

Recent Clinical Evidence

Research Evidence / Overview of Studies for Biperiden


Evidence for Use in Drug-Induced Movement Symptoms

This section will summarize the evidence base, primarily consisting of Randomized Controlled Trials (RCTs) and comparative studies, that was studied for movement difficulties, such as tremor and rigidity, in adult populations receiving certain medications.

Research has explored how Biperiden was evaluated in studies examining movement problems that can occur when individuals take certain medications for psychiatric conditions. Studies monitored outcomes related to systemic or functional imbalance, such as uncontrolled muscle stiffness and restlessness, using standardized rating scales. The populations studied were adults who had developed these extrapyramidal symptoms while receiving neuroleptic use.

Findings describe patterns observed in the studies related to outcomes describing episodic or acute changes over short, defined time intervals. However, comparative evidence is lacking for newer, non-anticholinergic treatments that are used today. Furthermore, there is limited information for long-term outcomes regarding the sustained use of Biperiden for managing these movement symptoms over extended periods.


Evidence for Use in Idiopathic Parkinsonism

This section will detail the nature of the research, which includes older clinical trials and single-dose assessments, that was studied for the motor symptoms of Parkinson's disease, such as tremor and stiffness.

Biperiden was evaluated in studies of individuals with Idiopathic Parkinson's Disease, research examining physical discomfort and motor symptoms. Studies explored research exploring short-term symptom changes using scales like the Unified Parkinson's Disease Rating Scale (UPDRS).

Data show patterns related to short-term outcomes describing episodic or acute changes measured in the populations studied. However, most of the evidence base is historical. The existing research reflects historical study designs, and comparative evidence is lacking for contemporary, large-scale RCTs focusing on Biperiden used alone (monotherapy). This means the existing research contributes to the broader evidence landscape but is considered to be of moderate weight overall.


Research Gaps and Uncertain Contexts

Research on Biperiden is not uniform across all potential applications, and evidence quality varies across studies. For certain proposed uses, such as preventing Post-Traumatic Epilepsy (PTE) following a brain injury, the research is currently categorized as low-weight. Studies conducted during these periods of increased symptom activity, such as a major Phase III trial for PTE, indicated that certainty remains low.

In non-approved contexts, such as the research examining temporary physiological imbalance related to addiction, data are still emerging from small-scale exploratory trials, and the certainty remains low.

Key Studies & References

  1. Initial clinical evidence on biperiden as antiepileptogenic after traumatic brain injury—a randomized clinical trial (NCT01048138)

Frequently Asked Questions (FAQ)

Common questions about Biperiden (FAQ)

Q: How quickly does Biperiden start working to relieve movement symptoms?

According to official product information, the oral tablet form typically reaches its highest concentration in the body within one to one and a half hours after a single dose. The injectable form is used for acute symptoms when a quick onset of effect is required to manage severe symptoms.


Q: Is it common to feel unusually hot or have less sweating while taking Biperiden?

Official documents indicate that this medicine can cause a decrease in sweating (anhidrosis), which may result in the body getting too hot. Because of this potential effect, patients may be cautioned about use in hot weather or during physical exercise.


Q: How long can a person safely take Biperiden for movement symptoms?

Regulatory records indicate that Biperiden is used as an add-on treatment or as part of a long-term plan for certain conditions. The duration of use is often determined by the length of the underlying condition being treated. Decisions regarding the duration of treatment are managed by a healthcare provider.


Q: Is Biperiden considered an addictive medication or does it have potential for dependence?

Official warnings note that Biperiden has been linked to reports of drug abuse due to short-acting mood-elevating or euphoric effects. Due to the potential for physical dependence with repeated use, official guidelines advise that discontinuation be managed with a gradual dose reduction.


Q: What happens if I forget to take a dose of Biperiden?

The official product information provides a protocol for managing a missed dose. This procedure typically involves taking the dose if remembered soon after the scheduled time, or otherwise skipping the missed dose and continuing with the regular schedule. The general principle is to avoid taking two doses at once.


Q: Does Biperiden affect Rapid Eye Movement (REM) sleep architecture?

Research suggests that Biperiden has been observed to alter the normal structure of sleep, including the potential for depression of REM sleep (the sleep stage associated with dreaming). This is one of the medicine’s known central nervous system effects.


Q: Does Biperiden help with all types of tremors?

The medicine is officially indicated for reducing the tremors, stiffness, and spasms associated with Parkinson's disease and drug-induced movement disorders. Official documents do not state its use or effectiveness for all types of tremors.


Q: Can Biperiden interact with common pain relievers like Tylenol (acetaminophen)?

Regulatory information indicates that anticholinergic agents like Biperiden can slow the movement of the stomach and intestines (gastrointestinal motility). This change may lead to a slight delay in the absorption of other medications taken orally, such as acetaminophen, and the clinical significance of this potential delay is managed by a prescriber.


Q: What does it mean if Biperiden is an 'anticholinergic' medication?

Biperiden is classified as an anticholinergic because it works by blocking the effects of the chemical messenger acetylcholine in the body. Specifically, it blocks muscarinic receptors in the central and peripheral nervous systems to help restore the necessary balance in motor pathways.


Q: What should I do if my mouth feels extremely dry while taking Biperiden?

Dryness of the mouth is a frequent and expected peripheral side effect resulting from the medicine’s anticholinergic activity. Official sources confirm the symptom's presence but do not provide specific guidance on management.


Q: Can Biperiden cause blood pressure changes, like postural hypotension?

The injectable form is noted to potentially cause orthostatic hypotension (a drop in blood pressure when standing up), as described in its official product information. Biperiden is also noted to potentially affect heart rate and blood pressure.


Q: What is the significance of the drug’s half-life for me as a patient?

The term half-life refers to the time it takes for half of the medicine to be eliminated from the body. For oral Biperiden, the half-life is approximately 18 to 24 hours. This time frame informs the typical schedule of divided daily doses for maintenance therapy.


Q: What precautions are needed if I have a history of liver or kidney problems?

Official labeling indicates that individuals with severe renal (kidney) or hepatic (liver) disease are typically advised to use the medicine cautiously. Specific dose adjustment data for patients with severe impairment is often not readily available or established.


Q: Is Biperiden excreted in human breast milk?

Information from regulatory sources indicates that Biperiden is presumed to pass into breast milk. Due to the potential for effects on the infant, official sources generally advise caution or avoidance of use during the lactation period.


Q: What are the most commonly reported anticholinergic side effects of Biperiden?

The safety profile of the drug is characterized by anticholinergic effects affecting the central nervous system and other bodily functions. Regulatory documents categorize side effects by system and frequency; however, they do not specify a ranked list of the most common peripheral anticholinergic side effects.


Q: Can Biperiden interact with medicines used for depression or other mental health conditions?

Official interaction warnings state that Biperiden can have additive Central Nervous System (CNS) effects when taken with other CNS depressants. The use of these combinations typically requires careful monitoring by a healthcare professional.


Q: What are the signs of an allergic reaction to Biperiden?

Official adverse reaction tables list hypersensitivity reactions as a very rare possibility with Biperiden use. The documents confirm that a hypersensitivity reaction may occur, but official documents do not specify the exact physical signs associated with these reactions.


Q: Is it possible for Biperiden to make involuntary movements, like tardive dyskinesia, worse?

Official warnings state that the medicine is associated with a potential for generalized dyskinesia (uncontrolled movements). Additionally, co-administration with other treatments has been linked to reports of choreiform movements. These reports reflect a need for careful monitoring of movement disturbances.


Q: Are there any known long-term cognitive effects associated with Biperiden use?

Official documents list short-term confusion and disturbance of memory as possible side effects. However, research evidence overviews note a lack of information regarding long-term outcomes and sustained cognitive effects related to prolonged use of Biperiden.


Q: Does Biperiden interact with any of the commonly prescribed antipsychotic medications?

Interaction profiles specify general warnings for combining Biperiden with CNS-acting drugs. It is explicitly noted that a class of antipsychotics, Phenothiazines, is contraindicated for use if a person is experiencing a Biperiden overdose, as it may intensify the toxicity.


Q: Is Biperiden used for purposes other than Parkinson's or drug-induced symptoms?

Research evidence overviews indicate that Biperiden has been evaluated in studies exploring its use in non-approved contexts, such as preventing Post-Traumatic Epilepsy and in research related to addiction. However, regulatory documentation emphasizes that these are research gaps with low certainty.

How should Biperiden be stored and disposed of?

How to Store and Dispose of Biperiden?

The official storage and disposal guidelines for Biperiden are defined by regulatory authorities to ensure product stability and safety.

Storage Requirement Official Guideline
Temperature Store at controlled room temperature, typically 15 C to 30 C (59 F to 86 F). Do not store above 25 C.
Protection Keep away from heat, moisture, and direct light. It is mandatory to keep the medicine from freezing.
Packaging Must be kept in a tight, light-resistant container and remain in its original packaging, including the outer carton.
Child Safety The medicine must be stored out of the sight and reach of children.
Stability Do not use the medication after the official expiry date printed on the label.

For disposal, official instructions prohibit discarding Biperiden in household trash, drains, or wastewater. Unused or expired medication should not be kept; patients are required to consult a healthcare professional or pharmacist regarding proper disposal methods, such as returning the product.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Biperiden found in:

A-Z Index: